Novo Nordisk expands business in LATAM market, promotes Saxenda to combat obesity issues
Date: 2017-06-20   Author: Saipriya Iyer  Category: #market

Novo Nordisk expands business in LATAM market, promotes Saxenda to combat obesity issues

Novo Nordisk, reputed player in global pharmaceutical market, is reportedly eager to expand its business in Latin America. The Danish healthcare company headquartered in Bagsværd, Denmark aims to explore new growth avenues in the region by increasing the marketing scale of its obesity drug, Saxenda. The firm already has affiliates in more than 75 countries and production facilities in 8 countries across the globe.

Novo Nordisk had already introduced Saxenda, the firm’s novel anti-obesity injection that is known to effectively combat obesity issues and improve the overall health of a patient, across the Latin American belt. The introduction of the medication was met with a tremendous response, owing to which Saxenda has already become successful across the region. This novel product, which was launched in 2015 by Novo Nordisk, possesses the same content - GLP-1 amino acid, that is present in the diabetes medicine named Victoza. As per reliable reports, Saxenda, which contributes nearly 2% of the company’s total sales, is expected to collect a revenue of greater than USD 1 billion by 2023. Income accrued by the firm from the product sales across Latin America in the first quarter of 2017, was twice the revenue collected from the sales in the last quarter of 2016.

Mexico, the country infamous for housing the world’s most obese population, offers a bright future for the obesity sector and can be a lucrative business avenue for the firm. But, the U.S. obesity market, which is still the largest revenue pocket for Novo Nordisk, has accounted for nearly 70% of the overall revenue of the firm in the first quarter of 2017. This newly introduced obesity reducing & weight loss maintaining product has dominated obesity business in the U.S.  despite its low-cost amounting to nearly USD 1,000 per month. The growth is mainly attributed to the growing unfulfilled medical requirements of the U.S. population.

According to estimates, nearly 600 million people across the globe are obese, with U.S. population contributing to just under 100 million. Novo is trying to enhance its drug production capacity and aims to expand its business through product penetration in newer markets. It is seeking to introduce Saxenda in more than 190 countries outside North America to further facilitate its global expansion. The world’s largest insulin manufacturer thus, is looking forward to experience tremendous success in the future by means of adopting diversification strategies and penetrating new markets.



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

Business-to-business E-commerce Market Comprehensive Study with Key Trends, Major Drivers and Challenges 2020-2026
Author: Sachin Pashte

This detailed presentation on ' Business-to-business E-commerce market' available at MarketStudyReport.com, features an exhaustive study conveying influential trends prevailing in the global business sphere. The report also presents signif...


Broadband Service Market to 2026: Growth Analysis by Manufacturers, Regions, Types and Applications
Author: Sachin Pashte

Market Study Report, LLC offers a latest study on ' Broadband Service market' featuring a holistic view of the market size, industry share, profit estimates, SWOT analysis and the regional landscape of the business. The report precisely ex...


Crisis Management System Market Global Growth, Opportunities, Industry Analysis & Forecast to 2026
Author: Sachin Pashte

Market Study Report, LLC, has recently added a report on ' Crisis Management System market' which offers a comprehensive synopsis of revolving market valuation, market size, SWOT analysis, revenue estimation and geographical spectrum of th...